Mirikizumab 300mg/15ml solution for infusion vials
- SNOMED code
42030211000001103- Active compound
- Mirikizumab
- Preferred name basis
- rINN - Recommended International Non-proprietary
- Prescribable
- ✅ Yes
- Dose form
- Discrete
- Dose size and units
- 15 ml, vial
- Ingredients
- Mirikizumab
— 20 mg
/ 1 ml
based on ingredient substance
- Form & Route
- solutioninfusion.intravenous
Solution for infusion, Intravenous - Controlled drug
- No Controlled Drug Status
Products
Omvoh 300mg/15ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd)
Omvoh 300mg/15ml concentrate for solution for infusion vials
- SNOMED code
42019211000001104- Supplier
- Eli Lilly and Company Ltd
- Licensed as
- Medicines - MHRA/EMA
- EMA (European Medicines Agency) Monitoring
- ▼ Yes, black triangle marked
- Availability restrictions
- None
- Licensed route
- Intravenous
| Pack name & code | Status | GTIN, EAN barcodes | Price | Prescribing | Reimbursement | Pack |
|---|---|---|---|---|---|---|
Omvoh 300mg/15ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) 1 vial42019311000001107 ref. pack | 💯 Available Legal category: POM | 5014602101923 | NHS Indicative Price £2,056 | • Hospital |
| — |
Reference packs
Mirikizumab 300mg/15ml solution for infusion vials 1 vial
- SNOMED code
42019111000001105- Quantity and unit
- 1 vial
- Packs